A cellular trojan horse for delivery of therapeutic nanoparticles into tumors

Nano Letters

Volumn 7, Issue 12, 2007, Pages 3759-3765

  Choi, Mi Ran ^a   Stanton Maxey, Katie J ^a   Stanley, Jennifer K ^a   Levin, Carly S ^b,c   Bardhan, Rizia ^b,c   Akin, Demir ^d   Badve, Sunil ^a   Sturgis, Jennifer ^d   Robinson, J Paul ^d   Bashir, Rashid ^d   Halas, Naomi J ^b,c   Clare, Susan E ^a  

^a INDIANA UNIVERSITY   (United States)

^b RICE UNIVERSITY   (United States)

^c Rice University   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIC REGIONS; MALIGNANT PROGRESSION; MONOCYTES;

CELL DEATH; MACROPHAGES; NANOPARTICLES; ONCOLOGY;

TUMORS;

ANTINEOPLASTIC AGENT; NANOPARTICLE;

ARTICLE; CELL HYPOXIA; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; MACROPHAGE; METHODOLOGY; MONOCYTE; NEOPLASM; SPECTROPHOTOMETRY; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL HYPOXIA; DRUG DELIVERY SYSTEMS; HUMANS; MACROPHAGES; MONOCYTES; NANOPARTICLES; NEOPLASMS; SPECTROPHOTOMETRY;

EID: 38049131877     PISSN: 15306984     EISSN: None     Source Type: Journal    
DOI: 10.1021/nl072209h     Document Type: Article

References (45)

1. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. J. Controlled Release 2000, 65, 271-284.
2. Loo, C.; Lowery, A.; Halas, N.; West, J.; Drezek, R. Nano Lett. 2005, 5, 709-711.
3. Primeau, A. J.; Rendon, A.; Hedley, D.; Lilge, L.; Tannock, I. F. Clin. Cancer Res. 2005, 11, 8782-8788.
4. Brown, J. M. Cancer Res. 1999, 59, 5863-5870.
5. Cairns, R. A.; Khokha, R.; Hill, R. P. Curr. Mol. Med. 2003, 3, 659-671.
6. Christofori, G. Nature 2006, 441, 444-450.
7. Kelly, P. M.; Davison, R. S.; Bliss, E.; McGee, J. O. Br. J. Cancer 1988, 57, 174-177.
8. Lewis, C. E.; Pollard, J. W. Cancer Res. 2006, 66, 605-612.
9. Leek, R. D.; Landers, R. J.; Harris, A. L.; Lewis, C. E. Br. J. Cancer 1999, 79, 991-995.
10. Tsutsui, S.; Yasuda, K.; Suzuki, K.; Tahara, K.; Higashi, H.; Era, S. Oncol. Rep. 2005, 14, 425-431.
11. Lin, E. Y.; Nguyen, A. V.; Russell, R. G.; Pollard, J. W. J. Exp. Med. 2001, 193, 727-740.
12. Hagemann, T.; Robinson, S. C.; Schulz, M.; Trümper, L.; Balkwill, F. R.; Binder, C. Carcinogenesis 2004, 25, 1543-1549.
13. Hagemann, T.; Wilson, J.; Kulbe, H.; Li, N. F.; Leinster, D. A.; Charles, K.; Klemm, F.; Pukrop, T.; Binder, C.; Balkwill, F. R. J. Immunol. 2005, 175, 1197-1205.
14. Goswami, S.; Sahai, E.; Wyckoff, J. B.; Cammer, M.; Cox, D.; Pixley, F. J.; Stanley, E. R.; Segall, J. E.; Condeelis, J. S. Cancer Res. 2005, 65, 5278-5283.
15. O'Sullivan, C.; Lewis, C. E.; Harris, A. L.; McGee, J. O. Lancet 1993, 342, 148-149.
16. Lewis. C.; Murdoch, C. Am. J. Pathol. 2005, 167, 627-635.
17. van Netten, J. P.; George, E. J.; Ashmead, B. J.; Fletcher, C.; Thornton, I. G.; Coy, P. Lancet 1993, 342, 872-873.
18. Sunderkotter, C.; Goebeler, M.; Schulze-Osthoff, K.; Bhardwaj, R.; Sorg, C. Pharmacol. Ther. 1991, 51, 195-216.
19. Lewis, C. E.; Leek, R.; Harris, A.; McGee, J. O. J. Leukocyte Biol. 1995, 57, 747-751.
20. Leek, R. D.; Lewis, C. E.; Whitehouse, R.; Greenall, M.; Clarke, J.; Harris, A. L. Cancer Res. 1996, 56, 4625-4629.
21. Mantovani, A.; Sozzani, S.; Locati, M.; Allavena, P.; Sica, A. Trends Immunol. 2002, 23, 549-555.
22. Hanada, T.; Nakagawa, M.; Emoto, A.; Nomura, T.; Nasu, N.; Nomura, Y. Int. J. Urol. 2000, 7, 263-269.
23. Wyckoff, J.; Wang, W.; Lin, E. Y.; Wang, Y.; Pixley, F.; Stanley, E. R.; Graf, T.; Pollard, J. W.; Segall, J.; Condeelis, J. Cancer Res. 2004, 64, 7022-7029.
24. Ohno, S.; Ohno, Y.; Suzuki, N.; Kamei, T.; Koike, K.; Inagawa, H.; Kohchi, C.; Soma, G.; Inoue, M. Anticancer Res. 2004, 24, 3335-3342.
25. Oosterling, S. J.; van der Bij, G. J.; Meijer, G. A.; Tuk, C. W.; van Garderen, E.; van Rooijen, N.; Meijer, S.; van der Sijp, J. R.; Beelen, R. H.; van Egmond, M. J. Pathol. 2005, 207, 147-155.
26. Zeineddine, N. S.; Avina, M. D.; Williams, C. C.; Wepsic, H. T.; Jadus, M. R. Immunol. Lett. 1999, 70, 63-68.
27. Elgert, K. D.; Alleva, D. G.; Mullins, D. W. J. Leukocyte Biol. 1998, 64, 275-290.
28. Wojtowicz-Praga, S. J. Immunother, 1997, 20, 165-177.
29. Oldenburg, S. J.; Averitt, R. D.; Westcott, S. L.; Halas, N. Chem. Phys. Lett. 1998, 288, 243-247.
30. Prodan, E.; Radloff, C.; Halas, N. J.; Nordlander, P. Science 2003, 302, 419-422.
31. Prodan, E.; Nordlander, P. Nano Lett. 2003, 3, 543-547.
32. Loo, C.; Lin, A.; Hirsch, L.; Lee, M. H.; Barton, J.; Halas, N.; West, J.; Drezek, R. Technol. Cancer Res. Treat. 2004, 3, 33-40.
33. Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; Rivera, B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13549-13554.
34. Prodan, E.; Lee, A.; Nordlander, P. Chem. Phys. Lett. 2002, 360, 325-332.
35. Tam, F.; Moran, C.; Halas. N. J. Phys. Chem. B 2004, 795, 17290-17294.
36. Oubre, C.; Nordlander, P. J. Phys. Chem. B 2004, 108, 17740-17747.
37. Wang, H.; Fu, K.; Drezek, R.; Halas, N. J. Appl. Phys. B 2006, 84, 191-196.
38. O'Neal, D. P.; Hirsch, L. R.; Halas, N. J.; Payne, J. D.; West, J. L. Cancer Lett. 2004, 209, 171-176.
39. http://www6.amershambiosciences.com/applic/upp00738.nsf/vLook-upDoc/ 224505666-P516/$file/71716700AF.pdf.
40. van der Meer, J. W.; van de Gevel, J. S.; Blussé van Oud Alblas, A.; Kramps, J. A.; van Zwet, T. L.; Leijh, P. C.; van Furth, R. Immunology 1982, 47, 617-625.
41. Aguirre, C. M.; Kaspar, T. R.; Radloff, C.; Halas, N. J. Nano Lett. 2003, 3, 1707-1711.
42. Wang, H.; Goodrich, G. P.; Tam, F.; Oubre, C.; Nordlander, P.; Halas, N. J. Phys. Chem. B 2005, 109, 11083-11087.
43. Owen, M. R.; Byrne, H. M.; Lewis, C. E. J. Theor. Biol. 2004, 226, 377-391.
44. Azenshtein, E.; Luboshits, G.; Shina, S.; Neumark, E.; Shahbazian, D.; Weil, M.; Wigler, N.; Keydar, I.; Ben-Baruch, A. Cancer Res. 2002, 62, 1093-1102.
45. http://rsb.info.nih.gov/ij/.